Literature DB >> 11252808

Epoxygenase metabolites. Epithelial and vascular actions.

J D Imig1.   

Abstract

Cytochrome P450 (CYP450) epoxygenase enzymes demonstrate organ and cell specific expression and each CYP450 enzyme isoform produces a distinct pattern of epoxyeicosatrienoic acids (EETs). Investigations are beginning to describe the regulation of specific tissue CYP450 epoxygenase isoforms that may be associated with alterations in organ function that occur during various physiological and pathophysiological states. The main biological actions of EETs are their ability to affect epithelial ion transport and vascular smooth muscle cell function. This chapter focuses on the organ localization and production of EETs and the action of EETs on epithelial and vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11252808     DOI: 10.1385/MB:16:3:233

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  151 in total

1.  11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle.

Authors:  P L Li; C L Chen; R Bortell; W B Campbell
Journal:  Circ Res       Date:  1999-08-20       Impact factor: 17.367

2.  Cytochrome P-450 arachidonate metabolites in rat kidney: characterization and hemodynamic responses.

Authors:  K Takahashi; J Capdevila; A Karara; J R Falck; H R Jacobson; K F Badr
Journal:  Am J Physiol       Date:  1990-04

3.  Calcium influx factor, further evidence it is 5, 6-epoxyeicosatrienoic acid.

Authors:  B A Rzigalinski; K A Willoughby; S W Hoffman; J R Falck; E F Ellis
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

4.  Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses.

Authors:  J D Imig; B T Pham; E A LeBlanc; K M Reddy; J R Falck; E W Inscho
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

5.  Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes.

Authors:  N J Alkayed; J Narayanan; D Gebremedhin; M Medhora; R J Roman; D R Harder
Journal:  Stroke       Date:  1996-05       Impact factor: 7.914

6.  Epoxyeicosatrienoic acids, potassium channel blockers and endothelium-dependent hyperpolarization in the guinea-pig carotid artery.

Authors:  T Chataigneau; M Félétou; J Duhault; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1998-02       Impact factor: 8.739

7.  Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid omega-hydroxylation and 11,12-epoxidation by CYP4A2 protein.

Authors:  M H Wang; D E Stec; M Balazy; V Mastyugin; C S Yang; R J Roman; M L Schwartzman
Journal:  Arch Biochem Biophys       Date:  1996-12-15       Impact factor: 4.013

8.  Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction.

Authors:  B Vazquez; A Rios; B Escalante
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

9.  Possible involvement of arachidonic acid metabolites of cytochrome P450 monooxygenase pathway in vasopressin-stimulated glycogenolysis in isolated rat hepatocytes.

Authors:  S Yoshida; A Hirai; Y Tamura; S Yoshida
Journal:  Arch Biochem Biophys       Date:  1990-08-01       Impact factor: 4.013

10.  Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.

Authors:  W B Campbell; D Gebremedhin; P F Pratt; D R Harder
Journal:  Circ Res       Date:  1996-03       Impact factor: 17.367

View more
  8 in total

1.  Cytochrome P450 2C24: Expression, Tissue Distribution, High-Throughput Assay, and Pharmacological Inhibition.

Authors:  Jun Yang; Melissa A VanAlstine; James G Phillips; Mark P Wentland; Lindsay B Hough
Journal:  Acta Pharm Sin B       Date:  2012-04       Impact factor: 11.413

2.  CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow.

Authors:  Jonathan S Williams; Paul N Hopkins; Xavier Jeunemaitre; Nancy J Brown
Journal:  J Hypertens       Date:  2011-10       Impact factor: 4.844

3.  Mitogenic activity and signaling mechanism of 2-(14,15- epoxyeicosatrienoyl)glycerol, a novel cytochrome p450 arachidonate metabolite.

Authors:  Jianchun Chen; Jian-Kang Chen; John R Falck; Jagadeesh Setti Guthi; Siddam Anjaiah; Jorge H Capdevila; Raymond C Harris
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

4.  Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.

Authors:  Arzu Ulu; Todd R Harris; Christophe Morisseau; Christina Miyabe; Hiromi Inoue; Gertrud Schuster; Hua Dong; Ana-Maria Iosif; Jun-Yan Liu; Robert H Weiss; Nipavan Chiamvimonvat; John D Imig; Bruce D Hammock
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

5.  Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics.

Authors:  Ahmed A El-Sherbeni; Mona E Aboutabl; Beshay N M Zordoky; Anwar Anwar-Mohamed; Ayman O S El-Kadi
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

6.  Association of EPHX2 R287Q Polymorphism with Diabetic Nephropathy in Chinese Type 2 Diabetic Patients.

Authors:  Liang Ma; Meihua Yan; Xiaomu Kong; Yongwei Jiang; Tingting Zhao; Hailing Zhao; Qian Liu; Haojun Zhang; Peng Liu; Yongtong Cao; Ping Li
Journal:  J Diabetes Res       Date:  2018-02-05       Impact factor: 4.011

7.  Inactivation of Cys674 in SERCA2 increases BP by inducing endoplasmic reticulum stress and soluble epoxide hydrolase.

Authors:  Gang Liu; Fuhua Wu; Xiaoli Jiang; Yumei Que; Zhexue Qin; Pingping Hu; Kin Sing Stephen Lee; Jian Yang; Chunyu Zeng; Bruce D Hammock; Xiaoyong Tong
Journal:  Br J Pharmacol       Date:  2020-01-30       Impact factor: 8.739

8.  Interaction between alcohol consumption and CYP 2C19 gene polymorphism in relation to oesophageal squamous cell carcinoma.

Authors:  Yun Shi; Guo-jun Luo; Li Zhang; Ji Shi; Dao-quan Zhang; Jian-min Chen; Xiao-bo Chen; Zhuo-dong Li; Qing Zhao
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.